{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T22:21:18Z","timestamp":1788560478032,"version":"build-2803163510"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2019,1,4]],"date-time":"2019-01-04T00:00:00Z","timestamp":1546560000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Support Care Cancer"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1007\/s00520-018-4602-6","type":"journal-article","created":{"date-parts":[[2019,1,4]],"date-time":"2019-01-04T07:54:57Z","timestamp":1546588497000},"page":"1163-1170","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Predictive factors for cancer-associated thrombosis in a large retrospective single-center study"],"prefix":"10.1007","volume":"27","author":[{"given":"J.","family":"Haltout","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Awada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Paesmans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Moreau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Klastersky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Machiels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Ignatiadis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7753-230X","authenticated-orcid":false,"given":"N.","family":"Kotecki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,1,4]]},"reference":[{"issue":"6","key":"4602_CR1","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1001\/archinte.160.6.809","volume":"160","author":"JA Heit","year":"2000","unstructured":"Heit JA, Silverstein MD, Mohr DN, Petterson TM, O\u2019Fallon WM, Melton LJ (2000) Risk factors for deep vein thrombosis and pulmonary embolism: a population-based case-control study. Arch Intern Med. 160(6):809\u2013815","journal-title":"Arch Intern Med."},{"issue":"1","key":"4602_CR2","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.beha.2008.12.009","volume":"22","author":"A Falanga","year":"2009","unstructured":"Falanga A, Panova-Noeva M, Russo L (2009) Procoagulant mechanisms in tumour cells. Best Pract Res Clin Haematol. 22(1):49\u201360","journal-title":"Best Pract Res Clin Haematol."},{"issue":"3","key":"4602_CR3","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.critrevonc.2003.10.003","volume":"50","author":"M Cicco De","year":"2004","unstructured":"De Cicco M (2004) The prothrombotic state in cancer: pathogenic mechanisms. Crit Rev Oncol Hematol 50(3):187\u2013196","journal-title":"Crit Rev Oncol Hematol"},{"issue":"4","key":"4602_CR4","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/j.patbio.2008.02.007","volume":"56","author":"D Farge-Bancel","year":"2008","unstructured":"Farge-Bancel D, Florea L, Bosquet L, Debourdeau P (2008) Treatment of venous thromboembolic disease in cancer patients. Pathol Biol (Paris) 56(4):220\u2013228","journal-title":"Pathol Biol (Paris)"},{"key":"4602_CR5","doi-asserted-by":"crossref","unstructured":"Connors JM (2014) Prophylaxis against venous thromboembolism in ambulatory patients with cancer. N Engl J Med. 370(26):2515-9","DOI":"10.1056\/NEJMra1401468"},{"issue":"6","key":"4602_CR6","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1016\/j.thromres.2009.12.023","volume":"125","author":"AA Khorana","year":"2010","unstructured":"Khorana AA (2010) Venous thromboembolism and prognosis in cancer. Thromb Res. 125(6):490\u2013493","journal-title":"Thromb Res."},{"issue":"10","key":"4602_CR7","doi-asserted-by":"publisher","first-page":"e452","DOI":"10.1016\/S1470-2045(16)30369-2","volume":"17","author":"D Farge","year":"2016","unstructured":"Farge D, Bounameaux H, Brenner B, Cajfinger F, Debourdeau P, Khorana AA et al (2016) International clinical practice guidelines including guidance for direct oral anticoagulants in the treatment and prophylaxis of venous thromboembolism in patients with cancer. Lancet Oncol. 17(10):e452\u2013e466","journal-title":"Lancet Oncol."},{"issue":"17","key":"4602_CR8","doi-asserted-by":"publisher","first-page":"2189","DOI":"10.1200\/JCO.2013.49.1118","volume":"31","author":"GH Lyman","year":"2013","unstructured":"Lyman GH, Khorana AA, Kuderer NM, Lee AY, Arcelus JI, Balaban EP et al (2013) Venous thromboembolism prophylaxis and treatment in patients with cancer: American Society of Clinical Oncology clinical practice guideline update. J Clin Oncol Off J Am Soc Clin Oncol. 31(17):2189\u20132204","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol."},{"issue":"10","key":"4602_CR9","doi-asserted-by":"publisher","first-page":"1746","DOI":"10.1111\/jth.12683","volume":"12","author":"M Nisio Di","year":"2014","unstructured":"Di Nisio M, Carrier M, Lyman GH, Khorana AA (2014) Subcommittee on Haemostasis and Malignancy. Prevention of venous thromboembolism in hospitalized medical cancer patients: guidance from the SSC of the ISTH. J Thromb Haemost JTH. 12(10):1746\u20131749","journal-title":"J Thromb Haemost JTH."},{"issue":"2 Suppl","key":"4602_CR10","doi-asserted-by":"publisher","first-page":"e195S","DOI":"10.1378\/chest.11-2296","volume":"141","author":"SR Kahn","year":"2012","unstructured":"Kahn SR, Lim W, Dunn AS, Cushman M, Dentali F, Akl EA et al (2012) Prevention of VTE in nonsurgical patients: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 141(2 Suppl):e195S\u2013e226S","journal-title":"Chest."},{"issue":"10","key":"4602_CR11","doi-asserted-by":"publisher","first-page":"4902","DOI":"10.1182\/blood-2007-10-116327","volume":"111","author":"AA Khorana","year":"2008","unstructured":"Khorana AA, Kuderer NM, Culakova E, Lyman GH, Francis CW (2008) Development and validation of a predictive model for chemotherapy-associated thrombosis. Blood. 111(10):4902\u20134907","journal-title":"Blood."},{"issue":"29","key":"4602_CR12","doi-asserted-by":"publisher","first-page":"4839","DOI":"10.1200\/JCO.2009.22.3271","volume":"27","author":"AA Khorana","year":"2009","unstructured":"Khorana AA, Connolly GC (2009 Oct 10) Assessing risk of venous thromboembolism in the patient with cancer. J Clin Oncol Off J Am Soc Clin Oncol. 27(29):4839\u20134847","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol."},{"issue":"12","key":"4602_CR13","doi-asserted-by":"publisher","first-page":"e59","DOI":"10.1136\/oem.2004.014472","volume":"61","author":"DB Richardson","year":"2004","unstructured":"Richardson DB (2004) An incidence density sampling program for nested case-control analyses. Occup Environ Med. 61(12):e59","journal-title":"Occup Environ Med."},{"issue":"12","key":"4602_CR14","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1634\/theoncologist.2013-0226","volume":"18","author":"GH Lyman","year":"2013","unstructured":"Lyman GH, Eckert L, Wang Y, Wang H, Cohen A (2013) Venous thromboembolism risk in patients with cancer receiving chemotherapy: a real-world analysis. The Oncologist. 18(12):1321\u20131329","journal-title":"The Oncologist."},{"issue":"3","key":"4602_CR15","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1111\/j.1538-7836.2006.01804.x","volume":"4","author":"JW Blom","year":"2006","unstructured":"Blom JW, Vanderschoot JPM, Oostindi\u00ebr MJ, Osanto S, van der Meer FJM, Rosendaal FR (2006) Incidence of venous thrombosis in a large cohort of 66,329 cancer patients: results of a record linkage study. J Thromb Haemost JTH. 4(3):529\u2013535","journal-title":"J Thromb Haemost JTH."},{"key":"4602_CR16","doi-asserted-by":"crossref","unstructured":"Blom JW, Doggen CJM, Osanto S, Rosendaal FR (2005) 419 Malignancies, prothrombotic mutations, and the risk of venous 420 thrombosis. JAMA. 293(6):715\u2013722","DOI":"10.1001\/jama.293.6.715"},{"issue":"10","key":"4602_CR17","doi-asserted-by":"publisher","first-page":"2339","DOI":"10.1002\/cncr.23062","volume":"110","author":"AA Khorana","year":"2007","unstructured":"Khorana AA, Francis CW, Culakova E, Kuderer NM, Lyman GH (2007) Frequency, risk factors, and trends for venous thromboembolism among hospitalized cancer patients. Cancer. 110(10):2339\u20132346","journal-title":"Cancer."},{"issue":"2","key":"4602_CR18","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1093\/annonc\/mdj068","volume":"17","author":"K Kr\u00f6ger","year":"2006","unstructured":"Kr\u00f6ger K, Weiland D, Ose C, Neumann N, Weiss S, Hirsch C et al (2006) Risk factors for venous thromboembolic events in cancer patients. Ann Oncol Off J Eur Soc Med Oncol. 17(2):297\u2013303","journal-title":"Ann Oncol Off J Eur Soc Med Oncol."},{"issue":"2","key":"4602_CR19","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1046\/j.1365-2141.2002.03886.x","volume":"119","author":"RA Bucek","year":"2002","unstructured":"Bucek RA, Reiter M, Quehenberger P, Minar E (2002) C-reactive protein in the diagnosis of deep vein thrombosis. Br J Haematol. 119(2):385\u2013389","journal-title":"Br J Haematol."},{"issue":"2","key":"4602_CR20","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1160\/TH05-04-0266","volume":"94","author":"EA Fox","year":"2005","unstructured":"Fox EA, Kahn SR (2005) The relationship between inflammation and venous thrombosis. A systematic review of clinical studies. Thromb Haemost. 94(2):362\u2013365","journal-title":"Thromb Haemost."},{"key":"4602_CR21","doi-asserted-by":"crossref","unstructured":"Lu H-Y, Liao K-M (2018) Increased risk of deep vein thrombosis in end-stage renal disease patients. BMC Nephrol [Internet].","DOI":"10.1186\/s12882-018-0989-z"},{"key":"4602_CR22","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.thromres.2018.07.029","volume":"170","author":"KL Cheung","year":"2018","unstructured":"Cheung KL, Bouchard BA, Cushman M (2018) Venous thromboembolism, factor VIII and chronic kidney disease. Thromb Res. 170:10\u201319","journal-title":"Thromb Res."},{"issue":"9","key":"4602_CR23","doi-asserted-by":"publisher","first-page":"1773","DOI":"10.1111\/jth.13378","volume":"14","author":"AS Mansfield","year":"2016","unstructured":"Mansfield AS, Tafur AJ, Wang CE, Kourelis TV, Wysokinska EM, Yang P (2016) Predictors of active cancer thromboembolic outcomes: validation of the Khorana score among patients with lung cancer. J Thromb Haemost JTH. 14(9):1773\u20131778","journal-title":"J Thromb Haemost JTH."},{"issue":"3","key":"4602_CR24","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1007\/s11739-012-0784-y","volume":"7","author":"M Verso","year":"2012","unstructured":"Verso M, Agnelli G, Barni S, Gasparini G, LaBianca R (2012) A modified Khorana risk assessment score for venous thromboembolism in cancer patients receiving chemotherapy: the Protecht score. Intern Emerg Med. 7(3):291\u2013292","journal-title":"Intern Emerg Med."},{"key":"4602_CR25","doi-asserted-by":"crossref","unstructured":"Kuderer NM, Culakova E, Lyman GH, Francis C, Falanga A, 383 Khorana AA (2016) Avalidated risk score for venous thromboem- 384 bolism is predictive of cancer progression and mortality. The 385 Oncologist. 21(7):861\u2013867","DOI":"10.1634\/theoncologist.2015-0361"}],"container-title":["Supportive Care in Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00520-018-4602-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-018-4602-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-018-4602-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,12]],"date-time":"2023-09-12T17:33:32Z","timestamp":1694540012000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00520-018-4602-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,4]]},"references-count":25,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,4]]}},"alternative-id":["4602"],"URL":"https:\/\/doi.org\/10.1007\/s00520-018-4602-6","relation":{},"ISSN":["0941-4355","1433-7339"],"issn-type":[{"value":"0941-4355","type":"print"},{"value":"1433-7339","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1,4]]},"assertion":[{"value":"29 May 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 December 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 January 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was approved by Jules Bordet Institute Ethics Committee.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}